Year |
Citation |
Score |
2008 |
Ojima I, Chen J, Sun L, Borella CP, Wang T, Miller ML, Lin S, Geng X, Kuznetsova L, Qu C, Gallager D, Zhao X, Zanardi I, Xia S, Horwitz SB, et al. Design, synthesis, and biological evaluation of new-generation taxoids. Journal of Medicinal Chemistry. 51: 3203-21. PMID 18465846 DOI: 10.1021/Jm800086E |
0.587 |
|
2005 |
Ojima I, Borella CP, Wu X, Bounaud PY, Oderda CF, Sturm M, Miller ML, Chakravarty S, Chen J, Huang Q, Pera P, Brooks TA, Baer MR, Bernacki RJ. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. Journal of Medicinal Chemistry. 48: 2218-28. PMID 15771464 DOI: 10.1021/Jm049483Y |
0.621 |
|
2002 |
Ojima I, Geng X, Wu X, Qu C, Borella CP, Xie H, Wilhelm SD, Leece BA, Bartle LM, Goldmacher VS, Chari RV. Tumor-specific novel taxoid-monoclonal antibody conjugates. Journal of Medicinal Chemistry. 45: 5620-3. PMID 12477344 DOI: 10.1021/Jm025540G |
0.564 |
|
2000 |
Ojima I, Lin S, Inoue T, Miller ML, Borella CP, Geng X, Walsh JJ. Macrocycle formation by ring-closing metathesis. Application to the syntheses of novel macrocyclic taxoids Journal of the American Chemical Society. 122: 5343-5353. DOI: 10.1021/Ja000293W |
0.581 |
|
1999 |
Ojima I, Wang T, Miller ML, Lin S, Borella CP, Geng X, Pera P, Bernacki RJ. Synthesis and structure-activity relationships of new second-generation taxoids. Bioorganic & Medicinal Chemistry Letters. 9: 3423-8. PMID 10617084 DOI: 10.1016/S0960-894X(99)00629-0 |
0.661 |
|
Show low-probability matches. |